Journal
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE
Volume 32, Issue 2, Pages 227-235Publisher
SPRINGER
DOI: 10.1007/s10334-018-0719-3
Keywords
Glycogen synthase kinase 3; CDP-choline; P-31 nuclear magnetic resonance spectroscopy; Lipid; Glucose; Choline
Funding
- University of Aberdeen Development Trust
Ask authors/readers for more resources
PurposeGlycogen synthase kinase 3 (GSK3) is a key controlling element of many cellular processes including cell-cycle progression and recent studies suggest that GSK3 is a potential anticancer target. Changes in glucose metabolism associated with GSK3 inhibition may impact on lipid synthesis, whilst lipid metabolites can act as molecular response markers.MethodsHere, SKBr3 breast and HCT8 colorectal cancer cells were treated with the GSK3 inhibitor SB216763, and [C-14 (U)] glucose and [H-3] choline incorporation into lipids was determined. Cell extracts from treated cells were subject to P-31 NMR spectroscopy.ResultsSB216763 treatment decreased choline incorporation into lipids and caused an accumulation of CDP-choline which was accompanied by decreased conversion of glucose into lipid components.ConclusionSB216763 profoundly inhibits phospholipid synthesis in cancer cells which demonstrate accumulation of CDP-choline detectable by P-31 NMR spectroscopy. Metabolic changes in lipid metabolism present potential response markers to drugs targeting GSK3.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available